Pacira Pharma (PCRX) Tops Q3 EPS by 4c
Get Alerts PCRX Hot Sheet
Join SI Premium – FREE
Pacira Pharma (NASDAQ: PCRX) reported Q3 EPS of $0.14, $0.04 better than the analyst estimate of $0.10. Revenue for the quarter came in at $52 million versus the consensus estimate of $52.2 million.
For earnings history and earnings-related data on Pacira Pharma (PCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- China Automotive Systems (CAAS) Tops Q4 EPS by 24c ; Offers Guidance
- Rex American Resources Corp. (REX) Tops Q4 EPS by 48c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!